ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Japan's Shionogi creating coronavirus vaccine using insects

Drugmaker aims for trials this year with eventual goal of 10 million doses

Japanese drugmaker Shionogi is working with the  National Institute of Infectious Diseases to develop a coronavirus vaccine, with the help of insects. It hopes to begin clinical trials later this year. (Source photo by Reuters)

TOKYO -- Japanese drugmaker Shionogi & Co. said Monday that it is developing a coronavirus vaccine with the help of insects and aiming to start clinical trials this year.

The technology behind the new medication was developed by Shionogi subsidiary UMN Pharma, a vaccine maker based in Akita, in northern Japan. The drugmaker is working with the health ministry in preparation for clinical trials. It hopes to eventually produce 10 million doses of the vaccine.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more